Vitamin D-deficient pigs, rats and chicks were repleted with four daily oral doses of crystalline ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) containing equal concentrations of each. At 24h after the last dose, the plasma of each species was analysed for vitamin D and 25-hydroxyvitamin D by standard methods. The mean
(± S.D.) ratios of plasma cholecalciferol to ergocalciferol concentration were 1.5 +0.1 (pig), 1.7 + 0.1 (rat) and 6.3 + 1.2 (chick). The mean ratios of plasma 25-hydroxycholecalciferol to 25-hydroxyergocalciferol concentration were 4.0 + 0.1 (pig), 0.4 + 0.02 (rat) and 10.7 + 3.4 (chick). The mean plasma cholecalciferol/ergocalciferol ratios for the 24,25-dihydroxy-, 25,26-dihydroxy-and 1,25-dihydroxy-derivatives in the pig were 2.6 + 0.6, 5.8 + 1.3 and 5.8 + 0.8 respectively. This is the first evidence that mammals other than the New World monkey, like birds, discriminate between ergocalciferol and cholecalciferol. These data, therefore, suggest that species discrimination between the different forms of vitamin D is probably a general phenomenon in mammals. Moreover, this is the first indication of a species (rat) that discriminates against a cholecalciferol metabolite in favour of an ergocalciferol metabolite. Species discrimination against particular forms of vitamin D may be important to the choice of experimental animal models for studying the regulation of vitamin D metabolism and may also be an important consideration in dietary vitamin supplementation.
Early studies with ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3) indicated that these two prohormones are equally bioactive in mammals (Bethke et al., 1946; Norman, 1979) . Consequently, ergocalciferol has been freely substituted for cholecalciferol as a dietary supplement for humans and for most commercially important mammals (DeLuca, 1978; Norman, 1979 (Napoli et al., 1979) . Moreover, the metabolism of both forms, as presently known, proceeds through the same intermediates, with the possible exception that 25(OH)D 23,26-lactone may be produced from cholecalciferol alone (Horst et al., 1979 (Horst et al., , 1981a . Chickens (Steenbock et al., 1932; Windaus & Trautman, 1937; Chen & Bosmann, 1964) and New World monkeys (Hunt et al., 1967) (Horst et al., 1979 (Horst et al., , 1981a Barton & Patin (1976) , with NaB3H4 substituted for NaBH4. Metabolites of [3a-3H]ergocalciferol were prepared in vivo in vitamin Ddeficient rats and purified to homogeneity by h.p.l.c. (Horst et al., 1981b) . Preparation of 1,25(OH)2D2 was from 25(OH)D2 by the procedure described by Jones et al. (1980) .
Animals and diets
Pigs, rats and chicks were fed vitamin D-deficient diets (Miller et al., 1964; Suda et al., 1970; Knutson & DeLuca, 1974 ) from 7 days, 21 days and 1 day of age respectively. After 4-5 weeks of the vitamin D-deficient diet, animals of each species were given, orally, an equal mass of cholecalciferol and ergocalciferol (molar ratio 1.03) in propylene glycol daily for 4 days. Ten pigs were given 50,ug (2000 i.u.) of each, whereas 20 chicks and 30 rats were given 2.5,ug (100 i.u.) of each. The concentrations of ergocalciferol and cholecalciferol in each preparation were confirmed by h.p.l.c. before the experiments. Blood samples were taken from the rat and the chicken via heart puncture and from the pig via the jugular vein before administration of vitamin D and again on day 5, 24 h after the last dose was given. Blood samples were also collected from chicks and pigs receiving commercial maintenance diets for a comparison of vitamin D and vitamin D metabolite concentrations in normal animals with the experimental animals.
Assays
The amount of blood drawn was: rat, 3-6 ml; pig, 20ml; chicken, 5-10ml. Plasma from chickens and rats was combined to make a total of ten samples/ 1) The flow rate of the column was 2 ml/min. described (Horst et al., 1979, 198 la,b) , except for the following modification. For separation of 1,25(OH)2D2 from 1,25(OH)2D3, the 1,25(OH)2D fraction used for competitive protein-binding analysis (Horst et al., 1979, 198 25,26(OH)2D were measured in the pig (Table 3) . Without exception, the plasma concentrations of the ergocalciferol metabolites were lower (P < 0.05) than those of their cholecalciferol counterparts. In addition, the cholecalciferol/ergocalciferol ratios of the dihydroxylated metabolites were higher than the cholecalciferol/ergocalciferol ratio. The data in Drescher et al. (1969) , Imrie et al. (1967) or Jones et al. (1975) . All of these previous experiments suggested that the point of discrimination against ergocalciferol by the chick was at the 25(OH)D level. The apparent discrepancy lies in the experimental design. These previous studies were performed with ratioisotopes given as a single intravenous dose of the radioactive vitamin D preparations. Thus intestinal absorption was effectively eliminated as a possible point of discrimination. Our experiments, however, were done by using the more physiological approach of chronic simultaneous oral administration of non-radioactive preparations of ergocalciferol and cholecalciferol. We also determined that discrimination beyond 25(OH)D is not evident in the pig (Table 3) .
The discrimination between ergocalciferol and cholecalciferol by the pig came as a surprise because work with growing pigs (Bethke et al., 1946) fully the photochemical conversion of 7-dehydrocholesterol into cholecalciferol. The pig, therefore, probably evolved with cholecalciferol as its major source of vitamin D. Evolution could have provided means for each species to more efficiently process the form of vitamin D to which it was exposed.
We have shown that the pig and rat, as well as the chick, discriminate between ergocalciferol and cholecalciferol when these vitamins are co-dosed orally. Metabolic discrimination between ergocalciferol and cholecalciferol in mammals other than the New World monkey has heretofore been undescribed. These data suggest that mammals in general may metabolize D vitamins differently, quantitatively if not qualitatively. These findings may have interesting ramifications concerning the choice of a D vitamin to fortify diets. It is quite possible that, for mammals like the pig, which have evolved with significant exposure to sunlight, dietary supplementation with ergocalciferol would be less efficient than dietary supplementation with cholecalciferol particularly if the animals were exposed to cholecalciferol at the same time. On the other hand, perhaps some caution is appropriate in using the rat as a mammalian model for study of quantitative differences in metabolism of cholecalciferol and ergocalciferol.
